World's Best Scientists 2026 revealed!
Cephalalgia
H-index 40

Cephalalgia

0333-1024

Published by: SAGE

https://journals.sagepub.com/home/cep

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 460 98 339 37

Additional Metrics

Number of Best Scientists*: 206
Documents by Best Scientists*: 434
Top 100 Ranked Scientists*: 4
SCIMAGO H-index: 148
SCIMAGO SJR: 1.367
Impact Factor: 4.6

Overview

Top Research Topics at Cephalalgia?

Migraine, Anesthesia, Internal medicine, Pediatrics and Physical therapy are the subjects of interest in Cephalalgia. In addition to Migraine research, the journal aims to explore topics under Placebo and Headaches. Studies on Placebo discussed in the journal link to the field of Clinical trial.

The Anesthesia study presented in Cephalalgia encompasses related topics like Cluster headache and also examines its connection to subjects such as In patient. The studies on Internal medicine discussed can also contribute to research in the domains of Endocrinology and Cardiology.

  • Migraine (48.68%)
  • Anesthesia (28.56%)
  • Internal medicine (18.88%)

What are the most cited papers published in the journal?

  • The International Classification of Headache Disorders, 3rd edition (beta version) (5428 citations)
  • Flunarizine in Prophylaxis of Childhood Migraine: A Double-Blind, Placebo-Controlled, Crossover Study (3282 citations)
  • A Report on the Journal 2004 (2354 citations)

Research areas of the most cited articles at Cephalalgia:

The most cited papers aim to foster the development of research in Migraine, Anesthesia, Internal medicine, Physical therapy and Pediatrics. The journal publications facilitate discussions on Migraine that incorporate concepts from other fields like Clinical trial and Headaches. The journal publications address concerns in the field of Anesthesia by exploring it in line with topics in Placebo which intersect with Tolerability subjects.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Disease
  • Surgery

The previous edition focused in particular on these issues:

The topics of Migraine, Internal medicine, 2019-20 coronavirus outbreak, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Calcitonin gene-related peptide are the focal point of discussions in Cephalalgia. The research on Migraine featured in Cephalalgia combines topics in other fields like Physical therapy, Clinical trial and Pediatrics. The research on Pediatrics discussed in the journal draws on the closely related field of Headaches.

The journal explores topics in Internal medicine which can be helpful for research in disciplines like Endocrinology and Cardiology. Cephalalgia facilitates the exploration of 2019-20 coronavirus outbreak in relation to the field of Pandemic. The Calcitonin gene-related peptide research presented in the journal explores the relationship between Monoclonal antibody and the closely related topic of Receptor.

The most cited articles from the last journal are:

  • Effect of lockdown during COVID-19 on migraine: A longitudinal cohort study. (12 citations)
  • A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention: (10 citations)
  • Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis. (8 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Cephalalgia (based on the number of publications) are:

  • Jes Olesen (246 papers) published 4 papers at the last edition, 4 less than at the previous edition,
  • Jean Schoenen (157 papers) absent at the last edition,
  • Peter J. Goadsby (144 papers) published 5 papers at the last edition the same number as at the previous edition,
  • Richard B. Lipton (123 papers) published 10 papers at the last edition, 3 more than at the previous edition,
  • David W. Dodick (116 papers) published 10 papers at the last edition, 1 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Cephalalgia (based on the number of publications) are:

  • University of Copenhagen (371 papers) published 21 papers at the last edition, 4 less than at the previous edition,
  • Mayo Clinic (182 papers) published 18 papers at the last edition, 4 more than at the previous edition,
  • Sapienza University of Rome (180 papers) published 4 papers at the last edition the same number as at the previous edition,
  • University of Pavia (153 papers) published 9 papers at the last edition, 5 more than at the previous edition,
  • Albert Einstein College of Medicine (147 papers) published 11 papers at the last edition, 3 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 17.81% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 37.22% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.78% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.44% of all publications and 40.56% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Contribution by Nurse Practitioners in the Clinical Studies

Nurse Practitioners (NPs) are playing an increasingly critical role in Cephalalgia research and other clinical trials. They often provide the necessary bridge between patients and the complex medical terminologies and experiment protocols. Their expertise is crucial in patient recruitment, ensuring adherence to study protocol, and conducting follow-ups to collect essential data. These healthcare professionals, with their multidisciplinary approach, contribute significantly to the successful completion of these research initiatives. As nursing professionals, their insights on the effects of various treatments, patient safety, and comfort are invaluable.

Focused nurse practitioner programs such as the {anchor} have been emphasizing research participation and knowledge translation, enabling NPs to contribute meaningfully to these clinical trials and patient care. NPs here are trained in specialized areas such as Pediatrics, Anesthesia, and Internal Medicine which are some of the frequent research topics at Cephalalgia, thereby they can provide specialized care and research support in these fields.

Moving forward, nurse practitioners will undoubtedly continue to play an essential role in clinical research conducted at Cephalalgia and beyond, ensuring safe and effective patient care and enabling smoother execution of complex clinical trials.

Top Publications

  • Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1).

    Messoud Ashina;Joel Saper;Roger Cady;Barbara A Schaeffler

    (2020)
    371 Citations
  • Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution.

    Edoardo Caronna;Alejandro Ballvé;Arnau Llauradó;Victor José Gallardo

    (2020)
    181 Citations
  • Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults.

    Hans-Christoph Diener;Cristina Tassorelli;David W Dodick;Stephan D Silberstein

    (2020)
    130 Citations
  • Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment.

    David W Dodick;Peter J Goadsby;Peter J Goadsby;Christian Lucas;Rigmor Jensen

    (2020)
    130 Citations
  • Vestibular migraine: An update on current understanding and future directions.

    Tzu Chou Huang;Shuu Jiun Wang;Shuu Jiun Wang;Amir Kheradmand

    (2020)
    111 Citations
  • Prevalence of neck pain in migraine: A systematic review and meta-analysis

    (2022)
    95 Citations
  • A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention:

    Messoud Ashina;David Doležil;Jo H Bonner;Lifen Zhou

    (2021)
    87 Citations
  • Persistent post-traumatic headache attributed to mild traumatic brain injury: Deep phenotyping and treatment patterns.

    Håkan Ashina;Afrim Iljazi;Haidar Muhsen Al-Khazali;Sait Ashina

    (2020)
    83 Citations
  • Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine.

    David W Dodick;Erin G Doty;Sheena K Aurora;Dustin D Ruff

    (2021)
    83 Citations
  • Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study.

    Stewart J Tepper;Messoud Ashina;Uwe Reuter;Jan Lewis Brandes

    (2020)
    81 Citations

Related Online Degrees & Career Pathways

For students interested in expanding their healthcare knowledge beyond traditional medical degrees, there are numerous online programs that offer flexibility and specialization. Pursuing an online nutritionist degree can be a great way to enter the wellness field, focusing on diet and health management without the long commitment of medical school.

Nurses looking to advance their careers often explore easiest RN to BSN online programs, which provide an accessible path to a Bachelor of Science in Nursing. These cheapest RN to BSN online options balance cost-effectiveness with quality education, helping RNs meet increasing professional standards.

For those aiming for leadership roles in healthcare, enrolling in 1 year MHA programs online can accelerate progress towards management positions. These fast-tracked master's degrees focus on healthcare administration, preparing graduates to oversee complex healthcare operations efficiently.

Additionally, specialized fields such as psychiatric mental health nursing are gaining prominence. Students can pursue PMHNP programs to become certified psychiatric mental health nurse practitioners, a rapidly growing career addressing critical mental health needs.

Best Scientists Contributing to This Journal

Recently Published Articles